Tzung-Bor Wei > DLA Piper LLP (US) > Palo Alto, United States > Lawyer Profile

DLA Piper LLP (US)
EAST PALO ALTO, CA 94303-2214
United States
Tzung-Bor Wei photo

Work Department

Intellectual Property and Technology; Corporate; Technology




Chung Wei advises public and private companies on business and technology-related transactions. He assists clients with structuring, negotiating and documenting intellectual property license agreements, joint research and development agreements, Internet-related business agreements, software as a service (SaaS) transactions, OEM agreements, distribution agreements, manufacturing and supply agreements and other commercial transactions involving intellectual property assets.

In addition, Chung counsels technology and emerging growth companies on corporate formations, venture financings, joint ventures, strategic transactions and mergers and acquisitions.

His clients come from a broad range of industries, such as software, social networking, mobile applications, hardware and life sciences.


J.D., Harvard Law School; M.S., Applied Mathematics, Harvard University; B.A., Harvard College

Lawyer Rankings

United States > Intellectual property > Patents: licensing

DLA Piper LLP (US) delivers ‘first class service’ and offers ‘a one-stop shop for all legal needs‘, thanks to the ‘impressive scope of its US and international practice‘. The group fields a strong transactional practice, but also excels in commercial licencing agreements and litigation settlements. Technology-related mandates account for the majority of recent highlight matters, but the group was also active for life sciences, automotive, retail and energy clients. Clients include Qualcomm, the University of Texas at Austin and Revolution Contraceptive. Practice head Mark Lehberg in San Diego, ‘exceptional IP attorney‘ Jeffrey Aronson and Victoria Lee in Silicon Valley, and Philadelphia’s Darius Gambino form the heart of the practice. Silicon Valley’s Tzung-Bor Wei made partner. Michael McGurk left to found McGurk Group LLC. John Garvey joined Noria Therapeutics and Shane Albright joined Goodwin.